Загрузка...

Relapsing-Remitting Multiple Sclerosis Patients' Experience with Natalizumab: A Phenomenological Investigation

This phenomenological investigation was undertaken to gain a better understanding of multiple sclerosis (MS) patients' experience with natalizumab (Tysabri; Biogen Idec Inc, Cambridge, MA) treatment and its impact on their quality of life (QOL). Twenty MS patients who were receiving natalizumab...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Miller, Colleen E., Karpinski, Mary, Jezewski, Mary Ann
Формат: Artigo
Язык:Inglês
Опубликовано: The Consortium of Multiple Sclerosis Centers 2012
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3882975/
https://ncbi.nlm.nih.gov/pubmed/24453731
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7224/1537-2073-14.1.39
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!